Cargando…
Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells
Multidrug resistance (MDR) is a major hindrance to curative chemotherapy of various human malignancies. Hence, novel chemotherapeutics must be evaluated for their recognition by MDR efflux transporters. Herein we explored the cytotoxic activity of synthetic tubulysin B (Tub-B, EC1009) derivatives (T...
Autores principales: | Stark, Michal, Assaraf, Yehuda G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564821/ https://www.ncbi.nlm.nih.gov/pubmed/28637003 http://dx.doi.org/10.18632/oncotarget.18385 |
Ejemplares similares
-
Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa
por: Gervasoni, Silvia, et al.
Publicado: (2022) -
Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance
por: Goler-Baron, Vicky, et al.
Publicado: (2011) -
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2014) -
Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
por: Zwama, Martijn, et al.
Publicado: (2018) -
Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia
por: Raz, Shachar, et al.
Publicado: (2014)